©The Author(s) 2021.
World J Diabetes. May 15, 2021; 12(5): 541-555
Published online May 15, 2021. doi: 10.4239/wjd.v12.i5.541
Published online May 15, 2021. doi: 10.4239/wjd.v12.i5.541
Table 2 Special considerations in prescribing newer antihyperglycemic agents to kidney transplant recipients
| Clinical evidence | Largely observational |
| Kidney function | Reduced glomerular filtration rate |
| Fluctuating glomerular filtration rate | |
| Post-transplant diuresis | |
| Surgically altered urinary tract | Urinary tract infections |
| Graft arterial anastomosis | Peripheral vascular disease |
| Immunosuppression | Fluctuating glucose control |
| Interaction with calcineurin inhibitors | |
| Urinary tract infections | |
| Gastrointestinal upset | Intravascular volume depletion |
| Dehydration | |
| Others | Post-transplant erythrocytosis |
- Citation: Montada-Atin T, Prasad GVR. Recent advances in new-onset diabetes mellitus after kidney transplantation. World J Diabetes 2021; 12(5): 541-555
- URL: https://www.wjgnet.com/1948-9358/full/v12/i5/541.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i5.541